Showing results (201-210 of 263) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, H Herr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trialC N Sternberg, J S de Bono, K N Chi, et al.
Cancer|December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsA D Seidman, H I Scher, M H Heinemann, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PETE C S C Etchebehere, H A Macapinlac, M Gonen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupT A Splinter, T Sahmoud, J Festen, et al.
Journal of the National Cancer Institute|February 26, 1999
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancerH I Scher, W M Kelly, Z F Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castrationO Smaletz, M Galsky, H I Scher, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancerL Sepp-Lorenzino, G Tjaden, M M Moasser, et al.
Pageof 27